Department of Radiology
Found 47 results
Filters: Keyword is Tissue Distribution  [Clear All Filters]
2024
Lundmark F, Vorobyeva A, Liu Y, Lindbo S, Xu T, Oroujeni M, Rinne SS, Rosenström U, Garousi J.  2024.  Reduction of renal activity retention of radiolabeled albumin binding domain‑derived affinity proteins using a non‑residualizing label strategy compared with a cleavable glycine‑leucine‑glycine‑lysine‑linker.. Mol Med Rep. 29(2)
2023
Kurtz K, Eibler L, Dacek MM, Carter LM, Veach DR, Lovibond S, Reynaud E, Qureshy S, McDevitt MR, Bourne C et al..  2023.  Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications.. Theranostics. 13(15):5469-5482.
Fung EK, Zanzonico PB.  2023.  Monitoring the biodistribution of radiolabeled therapeutics in mice.. Methods Cell Biol. 180:93-111.
2021
Dacek MM, Veach DR, Cheal SM, Carter LM, McDevitt MR, Punzalan B, Vargas DBurnes, Kubik TZ, Monette S, Santich BH et al..  2021.  Engineered Cells as a Test Platform for Radiohaptens in Pretargeted Imaging and Radioimmunotherapy Applications.. Bioconjug Chem. 32(4):649-654.
Kelly JM, Jeitner TM, Ponnala S, Williams C, Nikolopoulou A, DiMagno SG, Babich JW.  2021.  A Trifunctional Theranostic Ligand Targeting Fibroblast Activation Protein-α (FAPα).. Mol Imaging Biol. 23(5):686-696.
2020
Cheal SM, Patel M, Yang G, Veach D, Xu H, Guo H-F, Zanzonico PB, Axworthy DB, Cheung N-KV, Ouerfelli O et al..  2020.  An -Acetylgalactosamino Dendron-Clearing Agent for High-Therapeutic-Index DOTA-Hapten Pretargeted Radioimmunotherapy.. Bioconjug Chem. 31(3):501-506.
Cheal SM, McDevitt MR, Santich BH, Patel M, Yang G, Fung EK, Veach DR, Bell M, Ahad A, Vargas DBurnes et al..  2020.  Alpha radioimmunotherapy using Ac-proteus-DOTA for solid tumors - safety at curative doses.. Theranostics. 10(25):11359-11375.
Ballon DJ, Rosenberg JB, Fung EK, Nikolopoulou A, Kothari P, De BP, He B, Chen A, Heier LA, Sondhi D et al..  2020.  Quantitative Whole-Body Imaging of I-124-Labeled Adeno-Associated Viral Vector Biodistribution in Nonhuman Primates.. Hum Gene Ther. 31(23-24):1237-1259.
Deh K, Zaman M, Vedvyas Y, Liu Z, Gillen KMcCabe, Malley PO', Bedretdinova D, Nguyen T, Lee R, Spincemaille P et al..  2020.  Validation of MRI quantitative susceptibility mapping of superparamagnetic iron oxide nanoparticles for hyperthermia applications in live subjects.. Sci Rep. 10(1):1171.
2019
Kelly JM, Amor-Coarasa A, Ponnala S, Nikolopoulou A, Williams C, DiMagno SG, Babich JW.  2019.  Albumin-Binding PSMA Ligands: Implications for Expanding the Therapeutic Window.. J Nucl Med. 60(5):656-663.
Pandit-Taskar N, Zanzonico PB, Kramer K, Grkovski M, Fung EK, Shi W, Zhang Z, Lyashchenko SK, Fung AM, Pentlow KS et al..  2019.  Biodistribution and Dosimetry of Intraventricularly Administered I-Omburtamab in Patients with Metastatic Leptomeningeal Tumors.. J Nucl Med. 60(12):1794-1801.
Carrasquillo JA, Fine BM, Pandit-Taskar N, Larson SM, Fleming SE, Fox JJ, Cheal SM, O'Donoghue JA, Ruan S, Ragupathi G et al..  2019.  Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using Zr-DFO-MSTP2109A Anti-STEAP1 Antibody.. J Nucl Med. 60(11):1517-1523.
Binderup T, Duivenvoorden R, Fay F, van Leent MMT, Malkus J, Baxter S, Ishino S, Zhao Y, Sanchez-Gaytan B, Teunissen AJP et al..  2019.  Imaging-assisted nanoimmunotherapy for atherosclerosis in multiple species.. Sci Transl Med. 11(506)
Lin F, Prince MR, Spincemaille P, Wang Y.  2019.  Patents on Quantitative Susceptibility Mapping (QSM) of Tissue Magnetism.. Recent Pat Biotechnol. 13(2):90-113.
O'Donoghue JA, Danila DC, Pandit-Taskar N, Beylergil V, Cheal SM, Fleming SE, Fox JJ, Ruan S, Zanzonico PB, Ragupathi G et al..  2019.  Pharmacokinetics and Biodistribution of a [Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.. Mol Pharm. 16(7):3083-3090.
Tosi U, Kommidi H, Bellat V, Marnell CS, Guo H, Adeuyan O, Schweitzer ME, Chen N, Su T, Zhang G et al..  2019.  Real-Time, in Vivo Correlation of Molecular Structure with Drug Distribution in the Brain Striatum Following Convection Enhanced Delivery.. ACS Chem Neurosci. 10(5):2287-2298.
Kelly JM, Amor-Coarasa A, Ponnala S, Nikolopoulou A, Williams C, Thiele NA, Schlyer D, Wilson JJ, DiMagno SG, Babich JW.  2019.  A Single Dose of Ac-RPS-074 Induces a Complete Tumor Response in an LNCaP Xenograft Model.. J Nucl Med. 60(5):649-655.
2018
Lameijer M, Binderup T, van Leent MMT, Senders ML, Fay F, Malkus J, Sanchez-Gaytan BL, Teunissen AJP, Karakatsanis N, Robson P et al..  2018.  Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates.. Nat Biomed Eng. 2(5):279-292.
Kommidi H, Guo H, Nurili F, Vedvyas Y, Jin MM, McClure TD, Ehdaie B, Sayman HB, Akin O, Aras O et al..  2018.  F-Positron Emitting/Trimethine Cyanine-Fluorescent Contrast for Image-Guided Prostate Cancer Management.. J Med Chem. 61(9):4256-4262.
Amor-Coarasa A, Kelly J, Ponnala S, Vedvyas Y, Nikolopoulou A, Williams C, Jin MM, J Warren D, Babich JW.  2018.  [F]RPS-544: A PET tracer for imaging the chemokine receptor CXCR4.. Nucl Med Biol. 60:37-44.
Cheal SM, Ruan S, Veach DR, Longo VA, Punzalan BJ, Wu J, Fung EK, Kelly MP, Kirshner JR, Giurleo JT et al..  2018.  ImmunoPET Imaging of Endogenous and Transfected Prolactin Receptor Tumor Xenografts.. Mol Pharm. 15(6):2133-2141.
Kelly J, Amor-Coarasa A, Ponnala S, Nikolopoulou A, Williams C, Schlyer D, Zhao Y, Kim D, Babich JW.  2018.  Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors.. Eur J Nucl Med Mol Imaging. 45(11):1841-1851.
Singh R, Bellat V, Wang M, Schweitzer ME, Y Wu L, Tung C-H, Souweidane MM, Law B.  2018.  Volume of distribution and clearance of peptide-based nanofiber after convection-enhanced delivery.. J Neurosurg. 129(1):10-18.
2017
Kelly JM, Amor-Coarasa A, Nikolopoulou A, Wüstemann T, Barelli P, Kim D, Williams C, Zheng X, Bi C, Hu B et al..  2017.  Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer.. J Nucl Med. 58(9):1442-1449.
Schwartz J, Grkovski M, Rimner A, Schöder H, Zanzonico PB, Carlin SD, Staton KD, Humm JL, Nehmeh SA.  2017.  Pharmacokinetic Analysis of Dynamic F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.. J Nucl Med. 58(6):911-919.